Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11263190 | European Journal of Cancer | 2018 | 8 Pages |
Abstract
The AJCC 8th edition has some advantages over the previous version. However, patients with N2 and T4, who have been integrated into stage III, showed different treatment modalities and prognoses, and we proposed dividing stage III into IIIA (T1-3N2M0) and IIIB (T4NanyM0).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Meiying Song, Seung Bae Yoon, In Seok Lee, Tae Ho Hong, Ho Joong Choi, Moon Hyung Choi, Myung Ah Lee, Eun Sun Jung, Myung-Gyu Choi,